查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2095071

塑形設備市場－全球市場預測（2026-2032年）

Body Contouring Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，塑形設備市場規模將達到 53.7 億美元，複合年成長率為 12.55%。

主要市場統計數據
基準年 2025 23.4億美元
預計年份：2026年 26.2億美元
預測年份 2032 53.7億美元
複合年成長率 (%) 12.55%

塑形設備正在革新美容醫學，提供外科和非手術解決方案，以減少局部脂肪、緊緻肌膚、改善體型輪廓，並輔助減重後的體型再形成。消費者對美容手術的接受度不斷提高、皮膚科和醫療美容服務的普及，以及冷凍溶脂、射頻、雷射輔助溶脂、超音波、電磁肌肉刺激和微創能量平台等技術的持續創新，共同推動了這項需求的成長。檢驗的臨床和監管指南日益強調患者選擇、設備操作培訓、不利事件報告和循證治療結果，使安全性、有效性和個人化治療成為消費者購買決策的核心。隨著肥胖、代謝健康問題以及以健康為導向的外貌目標仍然是重要的公共衛生和生活方式議題，塑形技術正從小眾美容工具轉變為整形外科診所、皮膚科診所、醫院和專業健康中心使用的綜合美容治療方案。

塑形設備生態系的變革性變化

隨著患者對恢復時間更短、效果更自然、治療過程更輕鬆的塑形設備的需求日益成長，塑形設備市場正經歷重大變革。非侵入性和微創治療正在拓展腹部、側腰、大腿、手臂、下巴和其他目標區域的治療選擇，同時，在一次治療中改善脂肪減少、橘皮組織、皮膚鬆弛和肌肉緊實度的聯合方案也變得越來越普遍。監管機構的要求也影響​​產品開發，他們越來越重視臨床檢驗、真實世界安全性監測、能量輸送的精準性以及從業人員的培訓。同時，隨著消費者透過數位化管道所獲得的資訊越來越多，關於預期效果、禁忌症、治療週期和維護療程的透明度也變得癒發重要。醫療服務提供者正透過實證諮詢、影像學評估、個人化治療方案和術後追蹤來凸顯自身優勢，這反映出美容醫療的理念正從以設備主導的市場行銷轉向以患者療效主導的美容護理。

人工智慧對塑形設備的累積影響

人工智慧 (AI) 透過提升諮詢品質、治療方案製定、工作流程效率以及治療結果記錄，對整個塑形設備產業產生了累積的影響。 AI 驅動的影像診斷和分析能夠更準確地評估身體組成、皮膚鬆弛度、對稱性和治療進展，幫助臨床醫生規範治療前後的評估流程，並加強醫病溝通。在設備操作方面，智慧演算法正被擴大用於最佳化能量輸出、監測組織反應、支援安全標準並減少操作者之間的差異。 AI 還透過最佳化預約、患者細分、治療依從性提醒和治療後跟進來提升診所運作效率，同時數據分析可以識別不利事件、患者滿意度和再次治療需求方面的模式。然而，AI 的應用需要嚴格的管治，包括資料隱私、偏差控制、臨床監督、網路安全以及遵守醫療設備軟體法規。人工智慧在體型雕塑中最有效的用途不是取代，而是補充合格專業人員的臨床判斷，尤其是在患者的解剖結構、病歷和現實期望決定治療是否合適的情況下。

全球塑形需求的關鍵區域洞察

在亞太地區，由於醫療和美容基礎設施的不斷提高、都市區憑藉著成熟的皮膚科和整形外科診所網路、較高的消費者意識、明確的美容程序與保險報銷體系之間的界限，以及對醫療設備功效聲明、標籤檢視和安全性的嚴格監管，仍然是塑形技術高度發達的地區。在拉丁美洲，受巴西和墨西哥濃厚的美容文化推動，人們對塑形手術的興趣持續高漲，但手術的可及性因診所基礎設施、收入分配、資金籌措和監管成熟度而異。在歐洲，由於美容程序受到醫療監管、醫療設備的嚴格合規要求以及人們對經臨床驗證、恢復期短的治療方法的偏好，德國、法國、義大利、西班牙和英國等國的塑形設備正在被廣泛採用。在中東，高階美容診所、醫療旅遊中心和注重健康的消費者支出正在推動這項技術的普及，尤其是在海灣地區都市化的市場，這些地區的先進私人醫療保健系統正在不斷擴張。非洲的情況則更為不均衡，技術普及主要集中在都市區私立診所和醫療旅遊目的地，而更廣泛的普及則取決於經濟能力、訓練有素的從業人員數量、對進口的依賴程度以及醫療保健系統內部的各項優先事項。

影響塑形設備普及的關鍵群體特定見解。

在東協市場，塑形設備的重要性日益凸顯，尤其是在都市區，這得益於私人美容診所、醫療旅遊以及受數位化影響的美容潮流的蓬勃發展。然而，各成員國的法律規範、從業人員培訓和服務品質卻存在差異。海灣合作理事會（GCC）國家對高階、非侵入性美容手術有著強烈的親和性，這得益於高所得消費群體、專業診所以及優先考慮先進醫療技術的醫療旅遊策略。歐盟為塑形設備提供了最完善的法規環境之一，其醫療設備法規（MDR）強化了對製造商和經銷商在臨床證據、上市後監管、風險管理和合格評定方面的要求。在金磚國家，塑形設備的應用情況則各不相同。中國和印度擁有龐大的病患群體，且私人醫療保健服務覆蓋範圍不斷擴大；巴西擁有根深蒂固的美容文化；俄羅斯透過都市區私人診所維持市場需求；而南非則是非洲地區相對先進的中心。七國集團在技術採納、監管基準、臨床研究以及高階治療需求方面發揮著重要作用，尤其是在皮膚科、整形外科和醫療美容網路成熟的地區。雖然北約成員國並非經濟市場集團，但它們共同擁有眾多高所得國家和完善的醫療保健體系，其採購標準、對醫療設備安全性的期望、網路安全意識以及臨床培訓要求都會影響先進塑形技術的應用。

針對主要國家在塑形設備領域的商業機會進行分析

美國是塑形創新領域的中心，這得益於其龐大的美容手術量、廣泛的皮膚科和整形外科診所網路，以及消費者對非侵入性消脂和皮膚緊緻技術的高度認知。加拿大採用類似的臨床標準，相關技術主要集中在都市區私人診所和醫療美容中心。墨西哥受益於國內需求和跨境醫療旅遊，尤其以塑形服務為中心。巴西則在以身體為中心的美容手術方面擁有深厚的專業知識，並且仍然是美容醫學領域最重要的文化目的地之一。在歐洲，英國、德國、法國、義大利和西班牙透過成熟的美容醫學體系、尋求微創抗衰老的老齡化人口以及對臨床驗證效果日益成長的偏好支撐市場需求。德國和法國尤其以嚴格的醫療設備合規性和從業人員標準而聞名。在俄羅斯，大都會圈的私人診所也存在需求，但進口物流和監管方面的考量可能會影響醫療設備的供應。在中國，美容產業的普及主要受都市區消費者需求、私人美容醫療機構的快速發展以及美容醫療服務監管力度加大的推動。在印度，中產階級消費能力的提升、以皮膚科主導的美容醫療以及人們健康意識的增強，都促進了美容市場的擴張，但價格承受能力和從業人員培訓仍然是其普及的關鍵因素。日本和韓國在技術導向美容領域擁有強大的影響力，尤其是韓國，以其完善的美容醫療體系和消費者對改善外貌療法的早期接受度而聞名。在澳大利亞，標準化的醫療美容服務、消費者較高的健康意識以及皮膚科、整形外科和健康診所的廣泛應用，都支撐著美容行業的需求。

為領導企業提供實用建議

產業領導企業應優先考慮經臨床驗證的差異化優勢，投資於產生可靠的證據、透明的安全數據以及支持不同體型和治療部位獲得一致治療效果的設備設計。製造商和醫療機構需要加強從業人員培訓、患者篩檢方案和知情同意流程，以減少不利事件，並使患者的期望與實際治療效果相符。產品策略應強調多重模式平台、符合人體工學的易用性、個人化治療以及與影像、人工智慧評估和數位化患者管理工具的整合。銷售團隊應根據當地的監管要求、文化偏好、價格敏感度和診所基礎設施來製定市場進入計劃，而不是採用統一的全球模式。醫療機構可以透過建立系統化的治療流程來提高患者留存率，這些流程包括基準評估、聯合治療方案、生活方式指導和記錄在案的療效追蹤。此外，隨著人工智慧功能和數位化諮詢的日益普及，尤其是在美容醫學領域，領導企業也應投資於網路安全、資料隱私、上市後研究和符合倫理的行銷。

基於證據的身體塑形調查方法

本執行摘要採用系統性的二手研究方法編寫，重點關注來自醫療設備監管機構、臨床文獻、美容醫學專業組織、公共衛生資訊來源、同行評審期刊、標準化機構和區域政策文件的檢驗且公開的資訊。此調查方法強調對多方面證據進行交叉研究途徑，包括法規核准和授權、安全通告、臨床實踐趨勢、技術採納徵兆、醫療保健專業人員指南以及區域醫療保健基礎設施指標。本研究採用質性評估方法評估技術發展、區域採納趨勢、人工智慧整合、病患行為和競爭定位因素，而不依賴市場規模、市場佔有率或預測數據。研究結果與既定的醫療設備術語、目前的美容治療實踐和已知的區域法規環境保持一致。本研究特別注意避免宣傳性聲明、未經證實的績效說明和檢驗的商業性假設，以確保分析基於證據、平衡客觀，並適用於策略決策。

關於塑形設備未來發展的結論

在縮短恢復期、提高安全性、實現多方面治療效果以及數據驅動的個人化治療的需求推動下，塑形設備正朝著更加精細化、以患者為中心的美容醫學領域發展。區域和國家層面的普及模式反映了美容醫學成熟度、消費者收入水平、對塑形手術的文化態度、法律規範以及訓練有素的從業人員數量等方面的差異。人工智慧 (AI) 有望改善評估、工作流程和治療效果追蹤，但其價值取決於負責任的臨床管治和強大的資料保護。將經過檢驗的技術、從業人員培訓、與患者的透明溝通以及在地化的商業化策略相結合的行業相關人員，將更有利於建立信任並確立長期發展地位。隨著該領域的不斷成熟，最具永續的發展機會將來自於那些能夠提供可衡量的治療效果，同時又能維持高標準安全性、倫理性和臨床可靠性的設備和服務模式。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 塑形設備市場：依類型分類

  • 侵襲型
    • 切除手術設備
    • 傳統抽脂設備
    • 腹部重建手術（腹部整形術）使用器械
  • 微創和非侵入性
    • 冷凍溶脂
    • 雷射
    • 高頻
    • 超音波

第8章 塑形設備市場：功能性

  • 可攜式的
  • 固定式

第9章：塑形設備市場：依應用領域分類

  • 腹部塑形
    • 胃
    • 腰部
  • 臉部輪廓
    • 臉頰
    • 下巴
    • 下顎線
  • 下半身塑形
    • 臀部
    • 大腿
  • 上身塑形
    • 手臂
    • 後退

第10章：塑形設備市場：依最終用戶分類

  • 美容診所
  • 普通家庭用戶
  • 醫院
  • 醫療水療中心

第11章 塑形設備市場：依通路分類

  • 離線
  • 線上

第12章 塑形設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章 塑形設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章 塑形設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Allergan Aesthetics by AbbVie Inc.
  • Alma Lasers Ltd.
  • Asclepion Laser Technologies GmbH
  • Bausch Health Companies Inc.
  • BioPhotas, Inc
  • BTL Industries, Inc.
  • Candela Corporation
  • Cartessa Aesthetics, LLC
  • Cutera, Inc.
  • Cynosure, LLC
  • DEKA MELA srl by El.En. SpA
  • ENDYMED
  • Erchonia Corporation
  • Fotona DOO
  • Inmode Ltd
  • Lumenis Be Ltd.
  • Merz Pharma GmbH & Co. KGaA
  • MicroAire Surgical Instruments, LLC
  • Nouvag AG
  • Sciton Inc.
  • Sofwave Ltd.
  • Venus Concept
  • Zimmer MedizinSysteme GmbH
Product Code: MRR-563BF1FCED23

The Body Contouring Devices Market is projected to grow by USD 5.37 billion at a CAGR of 12.55% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.34 billion
Estimated Year [2026] USD 2.62 billion
Forecast Year [2032] USD 5.37 billion
CAGR (%) 12.55%

Body contouring devices are reshaping aesthetic medicine by offering surgical and non-surgical solutions that reduce localized fat, tighten skin, improve body shape, and support post-weight-loss remodeling. Demand is supported by rising consumer acceptance of aesthetic procedures, broader access to dermatology and medical spa services, and continued innovation across cryolipolysis, radiofrequency, laser-assisted lipolysis, ultrasound, electromagnetic muscle stimulation, and minimally invasive energy-based platforms. Verified clinical and regulatory guidance increasingly emphasizes patient selection, device training, adverse-event reporting, and evidence-based outcomes, making safety, efficacy, and treatment personalization central to purchasing decisions. As obesity, metabolic health concerns, and wellness-driven appearance goals remain prominent public health and lifestyle themes, body contouring technologies are moving from niche cosmetic tools toward integrated aesthetic treatment portfolios used by plastic surgery clinics, dermatology practices, hospitals, and specialized wellness centers.

Transformative Shifts in the Body Contouring Device Ecosystem

The body contouring devices landscape is undergoing significant transformation as patients increasingly seek procedures with shorter recovery times, natural-looking results, and lower procedural burden compared with traditional surgery. Non-invasive and minimally invasive modalities are expanding treatment options for the abdomen, flanks, thighs, arms, chin, and other target areas, while combination protocols are becoming more common to address fat reduction, cellulite appearance, laxity, and muscle tone in a single care pathway. Regulatory expectations are also influencing product development, with stronger focus on clinical validation, real-world safety monitoring, energy delivery precision, and operator training. At the same time, the rise of consumer education through digital channels has made transparency around expected outcomes, contraindications, treatment cycles, and maintenance sessions more important. Providers are differentiating through evidence-based consultations, imaging-assisted assessments, customized treatment planning, and post-procedure follow-up, reflecting a shift from device-led sales to patient-outcome-led aesthetic care.

Cumulative Impact of Artificial Intelligence on Body Contouring Devices

Artificial intelligence is creating cumulative impact across the body contouring devices sector by improving consultation quality, treatment planning, workflow efficiency, and outcome documentation. AI-enabled imaging and analytics can support more consistent assessment of body composition, skin laxity, symmetry, and treatment progress, helping clinicians standardize before-and-after evaluation while enhancing patient education. In device operation, intelligent algorithms are increasingly used to optimize energy delivery, monitor tissue response, support safety thresholds, and reduce variability between operators. AI also strengthens clinic operations through appointment optimization, patient segmentation, treatment adherence reminders, and post-treatment engagement, while data analytics can identify patterns in adverse events, satisfaction, and retreatment needs. However, adoption requires disciplined governance around data privacy, bias mitigation, clinical oversight, cybersecurity, and compliance with medical device software regulations. The most effective use of AI in body contouring will augment, not replace, qualified clinical judgment, especially where patient anatomy, medical history, and realistic expectations determine treatment suitability.

Key Regional Insights Across Global Body Contouring Demand

In Asia-Pacific, body contouring device adoption is supported by expanding medical aesthetics infrastructure, rising disposable income in urban centers, strong beauty and wellness cultures, and growing acceptance of non-surgical aesthetic procedures across China, Japan, South Korea, India, and Australia. North America remains a highly developed environment for body contouring technologies due to mature dermatology and plastic surgery networks, high consumer awareness, established separation of elective aesthetics from reimbursement systems, and robust oversight of medical device claims, labeling, and safety. Latin America demonstrates sustained interest in body-shaping procedures, supported by a strong cosmetic surgery culture in Brazil and Mexico, though access can vary by clinic infrastructure, income distribution, financing availability, and regulatory maturity. Europe shows broad adoption through medically supervised aesthetics, strict device compliance requirements, and preference for clinically validated, lower-downtime treatments across Germany, France, Italy, Spain, and the United Kingdom. The Middle East is gaining traction through premium aesthetic clinics, medical tourism hubs, and wellness-oriented consumer spending, particularly in urbanized Gulf markets where advanced private healthcare capacity is expanding. Africa remains more heterogeneous, with adoption concentrated in private urban clinics and medical tourism destinations, while broader penetration is shaped by affordability, trained practitioner availability, import dependence, and competing health system priorities.

Key Group Insights Shaping Body Contouring Device Adoption

ASEAN markets are becoming increasingly relevant for body contouring devices as private aesthetic clinics, medical tourism, and digitally influenced beauty trends expand across urban centers, although regulatory pathways, practitioner training, and service quality vary across member countries. The GCC shows strong alignment with premium non-invasive aesthetic procedures, supported by high-income consumer segments, specialized clinics, and health tourism strategies that prioritize advanced medical technologies. The European Union provides one of the most structured regulatory environments for body contouring devices, with the Medical Device Regulation strengthening clinical evidence, post-market surveillance, risk management, and conformity assessment expectations for manufacturers and distributors. BRICS countries present diverse adoption conditions: China and India offer large patient pools and expanding private healthcare access, Brazil has a deeply established aesthetic procedure culture, Russia maintains demand through urban private clinics, and South Africa serves as a comparatively advanced regional hub within Africa. G7 countries are important for technology adoption, regulatory benchmarking, clinical research, and premium procedure demand, particularly where dermatology, plastic surgery, and medical aesthetics networks are mature. NATO countries, while not an economic market bloc, collectively include many high-income and regulated healthcare systems where procurement standards, device safety expectations, cybersecurity awareness, and clinical training requirements influence adoption of advanced body contouring technologies.

Key Country Insights for Body Contouring Device Opportunities

The United States is a central environment for body contouring innovation due to high aesthetic procedure volumes, extensive dermatology and plastic surgery networks, and strong consumer familiarity with non-invasive fat reduction and skin-tightening technologies. Canada follows similar clinical standards, with adoption concentrated in urban private practices and medical aesthetic centers. Mexico benefits from domestic demand and cross-border medical tourism, particularly for body-shaping services, while Brazil remains one of the world's most culturally significant aesthetics destinations with deep expertise in body-focused cosmetic procedures. In Europe, the United Kingdom, Germany, France, Italy, and Spain support demand through established aesthetic medicine communities, aging populations seeking minimally invasive rejuvenation, and increasing preference for clinically substantiated outcomes; Germany and France are particularly shaped by rigorous medical device compliance and practitioner standards. Russia demonstrates demand in metropolitan private clinics, though import logistics and regulatory considerations can affect device availability. China's adoption is driven by urban consumer demand, rapid expansion of private aesthetics, and increasing regulatory scrutiny of medical beauty services. India is advancing through rising middle-class spending, dermatology-led aesthetics, and growing wellness awareness, while affordability and practitioner training remain important adoption factors. Japan and South Korea are highly influential in technology-oriented aesthetics, with South Korea especially recognized for sophisticated beauty medicine ecosystems and early consumer adoption of appearance-focused treatments. Australia supports demand through regulated medical aesthetics, high consumer awareness, and adoption in dermatology, cosmetic surgery, and wellness-oriented clinics.

Actionable Recommendations for Body Contouring Device Leaders

Industry leaders should prioritize clinically validated differentiation by investing in robust evidence generation, transparent safety data, and device designs that support consistent outcomes across diverse body types and treatment areas. Manufacturers and providers should strengthen practitioner training, patient screening protocols, and informed consent processes to reduce adverse events and align expectations with realistic outcomes. Product strategies should emphasize multi-modality platforms, ergonomic usability, treatment personalization, and integration with imaging, AI-assisted assessment, and digital patient management tools. Commercial teams should tailor market entry plans to local regulatory requirements, cultural preferences, pricing sensitivity, and clinic infrastructure rather than applying a uniform global model. Providers can improve retention by building structured treatment journeys that include baseline assessment, combination therapy recommendations, maintenance planning, lifestyle guidance, and documented outcome tracking. Leaders should also invest in cybersecurity, data privacy, post-market surveillance, and ethical marketing, particularly as AI-enabled features and digital consultations become more common in aesthetic medicine.

Research Methodology for Evidence-Based Body Contouring Insights

This executive summary is developed using a structured secondary research approach focused on verified and publicly available information from medical device regulators, clinical literature, professional aesthetic medicine associations, public health sources, peer-reviewed journals, standards bodies, and regional policy documentation. The methodology emphasizes triangulation of evidence across regulatory clearances, approvals, safety communications, clinical procedure trends, technology adoption signals, practitioner guidance, and regional healthcare infrastructure indicators. Qualitative assessment is used to evaluate technology shifts, regional adoption dynamics, AI integration, patient behavior, and competitive positioning factors without relying on market sizing, market share, or forecasting. Insights are reviewed for consistency with established medical device terminology, current aesthetic treatment practices, and known regional regulatory environments. Particular attention is given to avoiding promotional claims, unsupported performance statements, and unverified commercial assumptions, ensuring that the analysis remains evidence-led, balanced, and suitable for strategic decision-making.

Conclusion on the Future of Body Contouring Devices

Body contouring devices are evolving into a more sophisticated, patient-centered category within aesthetic medicine, driven by demand for lower-downtime treatments, improved safety controls, multi-modality outcomes, and data-supported personalization. Regional and country-level adoption patterns reflect differences in medical aesthetics maturity, consumer income, cultural attitudes toward body-shaping procedures, regulatory oversight, and availability of trained practitioners. Artificial intelligence is expected to enhance assessment, workflow, and outcome tracking, but its value depends on responsible clinical governance and strong data protection. Industry participants that combine validated technology, practitioner education, transparent patient communication, and localized commercialization strategies will be better positioned to build trust and long-term relevance. As the sector continues to mature, the most resilient opportunities will come from devices and service models that deliver measurable outcomes while maintaining high standards for safety, ethics, and clinical credibility.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Body Contouring Devices Market, by Type

  • 7.1. Introduction
  • 7.2. Invasive
    • 7.2.1. Excisional Surgery Devices
    • 7.2.2. Traditional Liposuction Devices
    • 7.2.3. Tummy Tucks (Abdominoplasty) Devices
  • 7.3. Minimally & Non-Invasive
    • 7.3.1. Cryolipolysis
    • 7.3.2. Laser
    • 7.3.3. Radiofrequency
    • 7.3.4. Ultrasound

8. Body Contouring Devices Market, by Functionality

  • 8.1. Introduction
  • 8.2. Portable
  • 8.3. Stationary

9. Body Contouring Devices Market, by Application

  • 9.1. Introduction
  • 9.2. Abdomen Reshaping
    • 9.2.1. Belly
    • 9.2.2. Waist
  • 9.3. Facial Contouring
    • 9.3.1. Cheeks
    • 9.3.2. Chin
    • 9.3.3. Jawline
  • 9.4. Lower Body Contouring
    • 9.4.1. Buttocks
    • 9.4.2. Thigh
  • 9.5. Upper Body Contouring
    • 9.5.1. Arm
    • 9.5.2. Back

10. Body Contouring Devices Market, by End User

  • 10.1. Introduction
  • 10.2. Cosmetic Clinics
  • 10.3. Home Users
  • 10.4. Hospitals
  • 10.5. Medical Spas

11. Body Contouring Devices Market, by Distribution Channel

  • 11.1. Introduction
  • 11.2. Offline
  • 11.3. Online

12. Body Contouring Devices Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Body Contouring Devices Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Body Contouring Devices Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2025
  • 15.2. FPNV Positioning Matrix, 2025
  • 15.3. Market Concentration Analysis, 2025
    • 15.3.1. Concentration Ratio (CR)
    • 15.3.2. Herfindahl Hirschman Index (HHI)
  • 15.4. Recent Developments & Impact Analysis, 2025
  • 15.5. Product Portfolio Analysis, 2025
  • 15.6. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Allergan Aesthetics by AbbVie Inc.
  • 16.2. Alma Lasers Ltd.
  • 16.3. Asclepion Laser Technologies GmbH
  • 16.4. Bausch Health Companies Inc.
  • 16.5. BioPhotas, Inc
  • 16.6. BTL Industries, Inc.
  • 16.7. Candela Corporation
  • 16.8. Cartessa Aesthetics, LLC
  • 16.9. Cutera, Inc.
  • 16.10. Cynosure, LLC
  • 16.11. DEKA M.E.L.A. srl by El.En. S.p.A.
  • 16.12. ENDYMED
  • 16.13. Erchonia Corporation
  • 16.14. Fotona D.O.O.
  • 16.15. Inmode Ltd
  • 16.16. Lumenis Be Ltd.
  • 16.17. Merz Pharma GmbH & Co. KGaA
  • 16.18. MicroAire Surgical Instruments, LLC
  • 16.19. Nouvag AG
  • 16.20. Sciton Inc.
  • 16.21. Sofwave Ltd.
  • 16.22. Venus Concept
  • 16.23. Zimmer MedizinSysteme GmbH

LIST OF FIGURES

  • FIGURE 1. GLOBAL BODY CONTOURING DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BODY CONTOURING DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BODY CONTOURING DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BODY CONTOURING DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BODY CONTOURING DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 23. GLOBAL BODY CONTOURING DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL BODY CONTOURING DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL EXCISIONAL SURGERY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL EXCISIONAL SURGERY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL EXCISIONAL SURGERY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL TRADITIONAL LIPOSUCTION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL TRADITIONAL LIPOSUCTION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TRADITIONAL LIPOSUCTION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TUMMY TUCKS (ABDOMINOPLASTY) DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TUMMY TUCKS (ABDOMINOPLASTY) DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL TUMMY TUCKS (ABDOMINOPLASTY) DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL MINIMALLY & NON-INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL MINIMALLY & NON-INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL MINIMALLY & NON-INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CRYOLIPOLYSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CRYOLIPOLYSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CRYOLIPOLYSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL LASER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL LASER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL LASER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RADIOFREQUENCY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RADIOFREQUENCY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RADIOFREQUENCY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ULTRASOUND MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ULTRASOUND MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ULTRASOUND MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ABDOMEN RESHAPING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ABDOMEN RESHAPING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ABDOMEN RESHAPING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BELLY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BELLY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BELLY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WAIST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WAIST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WAIST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL FACIAL CONTOURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL FACIAL CONTOURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL FACIAL CONTOURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CHEEKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CHEEKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CHEEKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CHIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CHIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CHIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL JAWLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL JAWLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL JAWLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL LOWER BODY CONTOURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LOWER BODY CONTOURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LOWER BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BUTTOCKS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BUTTOCKS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BUTTOCKS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL THIGH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL THIGH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL THIGH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL UPPER BODY CONTOURING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL UPPER BODY CONTOURING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL UPPER BODY CONTOURING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ARM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ARM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ARM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BACK MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BACK MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BACK MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COSMETIC CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COSMETIC CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL COSMETIC CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL HOME USERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL HOME USERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOME USERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MEDICAL SPAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MEDICAL SPAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL MEDICAL SPAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 101. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 102. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 103. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 104. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 105. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 106. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 107. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 108. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 130. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 169. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 170. AFRICA BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 185. GCC BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. GCC BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 187. GCC BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 188. GCC BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 189. GCC BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. GCC BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 191. GCC BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 192. GCC BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 193. GCC BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 194. GCC BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. GCC BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. G7 BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 221. G7 BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. G7 BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 223. G7 BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 224. G7 BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 225. G7 BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 226. G7 BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 227. G7 BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 228. G7 BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 229. G7 BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 230. G7 BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 231. G7 BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. NATO BODY CONTOURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. NATO BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. NATO BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 235. NATO BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 237. NATO BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 239. NATO BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 240. NATO BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 241. NATO BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 242. NATO BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 243. NATO BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL BODY CONTOURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 251. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 252. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 253. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 254. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 255. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 256. UNITED STATES BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 257. CANADA BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 258. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 259. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 260. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 261. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 262. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 264. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 265. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 266. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 267. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. CANADA BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. MEXICO BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 271. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 272. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 273. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 274. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 275. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 276. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 277. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 278. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 279. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. MEXICO BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 281. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 282. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 284. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 285. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 286. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 287. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 288. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 289. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 290. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 291. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. BRAZIL BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED KINGDOM BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 305. GERMANY BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 306. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 307. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 308. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 309. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 310. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 311. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 312. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 313. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 314. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 315. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 316. GERMANY BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 317. FRANCE BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 318. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 319. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 320. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 321. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 322. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 323. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 324. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 325. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 326. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 327. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 328. FRANCE BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 329. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 330. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 331. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 332. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 333. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 334. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 336. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 337. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 338. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY UPPER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 339. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 340. RUSSIA BODY CONTOURING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 341. ITALY BODY CONTOURING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 342. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY TYPE, 2018-2032 (USD MILLION)
  • TABLE 343. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 344. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY MINIMALLY & NON-INVASIVE, 2018-2032 (USD MILLION)
  • TABLE 345. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY FUNCTIONALITY, 2018-2032 (USD MILLION)
  • TABLE 346. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 347. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY ABDOMEN RESHAPING, 2018-2032 (USD MILLION)
  • TABLE 348. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY FACIAL CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 349. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY LOWER BODY CONTOURING, 2018-2032 (USD MILLION)
  • TABLE 350. ITALY BODY CONTOURING DEVICES MARKET SIZE, BY UPPER